These investigators demonstrated that transgenic mice selectively expressing PIM3 in the liver developed hepatocellular carcinoma more frequently than wild type mice, and that inhibition of PIM3 decreased cell proliferation and apoptosis in hepatocellular carcinoma [9, 16]. This evidence concerns the gene PIM3 and hepatocellular carcinoma.